When insulin costs more than you have
The emergency option most people do not know exists, the $35 programs, and where to start looking. Links to the programs themselves, because only they can tell you what you qualify for.
4 min read
Rationing insulin is common enough that it has been measured, and it is the kind of problem that gets worse quietly. People stretch a vial, skip a correction, wait a week for a refill. If that is where you are right now, start with the next paragraph rather than the whole article.
If you are nearly out today
Novo Nordisk runs a one-time immediate supply program: a free, short-term supply, up to 3 vials or 2 packs of pens, for people in urgent need. It sits on the same page as their other cost programs and it is easy to scroll past, which is why it is at the top of this article instead of the bottom.
It is a bridge, not a plan. It buys you the weeks you need to sort out one of the longer-term options below, and it exists precisely because the alternative is someone rationing.
The $35 programs
Both major insulin makers cap a month's supply at $35 for people who qualify, and the qualifying rules are not the same.
Lilly's Insulin Value Program covers a one-month fill of their covered insulins at $35, for people with commercial insurance and for people paying cash. Federal program enrollees are excluded by government rules, so Medicare, Medicaid, VA and TRICARE do not go through this one.
Novo Nordisk's MyInsulinRx covers a monthly supply of any combination of their covered insulins at $35. They run a separate patient assistance program aimed at people who are uninsured or on Medicare, which can supply insulin at no charge.
Notice that the exclusions point in opposite directions. If one program turns you away because of how you are insured, that is often the exact reason the other one might not.
If you are on Medicare
Insulin is capped at $35 a month under Medicare, with no deductible applying first. This is federal and it is not something you apply for through a manufacturer.
If you are on a commercial plan
There is no federal cap. Around half of states have passed their own copay limits, and those only reach state-regulated plans, which is not every plan. The rules change often enough that we are not going to list all fifty here and let them rot. The ADA keeps the current picture in one place, including which states have caps and what the manufacturer programs currently offer, and that is the right first stop.
The cheaper-insulin conversation
Human insulin, the older kind, is available at several national pharmacies for a fraction of analog prices, sometimes around $25 a vial. It is genuinely cheaper and it is genuinely different: the timing curves are not the same, so prebolus timing, correction behaviour and overnight profiles all shift.
That makes it a real option and a real conversation. It is not a swap to make on your own between refills, and anyone who tells you otherwise is skipping the part that matters.
Every program described here was read from the organisation's own page in August 2026. Programs change, sometimes mid-year. If a page says something different from this article, the page is right and we are not.